Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan

Abstract

Bcrp1 mediates apically directed drug transport, appears to reduce drug bioavailability, and protects fetuses against drugs. We propose that strategic application of BCRP inhibitors may thus lead to more effective oral chemotherapy with topotecan or other BCRP substrate drugs.